科研之友
微信
新浪微博
Facebook
分享链接
摘要
In the current issue of Cancer, Pasqualini and colleagues report on a study in which they target prostatic tumor vasculature signatures with an apoptosis-inducing, peptidomimetic drug. The authors of this editorial place this vascular-targeting discovery into a broader clinical context while focusing on opportunities and challenges in implementing it further.
- 出版日期2015-7-15
